Skip to content

The Therapeutic Effects of Phellinus from Old Mulberry Trees on Breast Nodules and Related Research

The Therapeutic Effects of Phellinus from Old Mulberry Trees on Breast Nodules and Related Research

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000722
Enrollment
Unknown
Registered
2026-03-25
Start date
2025-07-10
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast nodules

Interventions

research group:Oral administration of old mulberry tree sanghuang: The decoction method is a substitute decoction, using 4g of old mulberry tree sanghuang per day. For example, if the patient is presc

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Western Medicine Diagnostic Criteria: Refer to "Evaluation, Diagnosis, and Management of Breast Nodules" and relevant literature on breast nodules for diagnostic standards. Patients with breast nodules confirmed by color Doppler ultrasonography with a maximum diameter =10mm and classified as BI-RADS category 3 or below.Traditional Chinese Medicine Diagnostic Criteria: Refer to the "Diagnostic and Efficacy Standards for TCM Diseases" for the diagnosis of breast nodules: 1) Most nodules are located in the upper outer quadrant of the breast; they feel like small, firm nodules the size of beans, may be tender, and are not adherent to surrounding tissue; 2) The breast may experience swelling and pain, which fluctuates with emotions, often worsening before menstruation and easing afterward; 3) Color Doppler or other examinations can assist in diagnosis.Inclusion Criteria:1) Meet the above diagnostic criteria;2) Nodule maximum diameter =10mm;3) BI-RADS classification category 3 or below;4) Age between 18 and 60 years;5) Informed and voluntarily participating in this clinical study;6) Possess basic cognitive and communication abilities, and can cooperate with completing the assessment scales.

Exclusion criteria

Exclusion criteria: 1) Patients with consciousness disorders or mental illness, or those with diabetes, severe cardiovascular, cerebrovascular, liver, kidney, or other organic damage, immune system diseases, or a history of malignant breast tumors;2) Patients whom the doctor determines require surgical intervention;3) BIRADS category 0, with additional mammography, MRI, or other indications of breast lesions;4) Patients with other malignant tumors requiring surgical treatment;5) People allergic to fungi, pregnant or breastfeeding women;6) Patients currently receiving other medications or participating in related treatment studies that may affect the results of this study;7) Patients with poor compliance with the protocol, deemed by the researcher as unsuitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
breast lump size;texture of breast;breast pain;

Secondary

MeasureTime frame
mental condition;

Countries

China

Contacts

Public ContactXidong Gu

The First Affiliated Hospital of Zhejiang Chinese Medical University

guxidong@163.com+86 137 7787 5352

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026